transdifferentiation
/ tranz-dif-er-en-shee-AY-shun /
Imagine a trained electrician retraining directly into a plumber without first going back to being a wide-eyed student of nothing in particular — switching one finished profession straight into another. Transdifferentiation is the cellular version of that career switch: one specialized cell type converting directly into a different specialized type, without first rewinding all the way back to a stem-cell state.
Precisely, transdifferentiation is the conversion of one already-differentiated cell type into another differentiated cell type. It contrasts with the usual reprogramming route, which first sends a cell back to pluripotency and then forward again. In transdifferentiation the cell skips that detour, jumping more or less straight from one identity to another, often by forcing it to express the master transcription factors of the target cell type. It can happen rarely in nature and can be driven deliberately in the lab.
Transdifferentiation matters because it hints at a faster, more direct route to making needed cell types — for example, coaxing one abundant cell type directly into a scarce one for repair, without ever passing through a risky pluripotent stage that could form tumors. But it is still early and difficult: converted cells are often incompletely transformed or unstable, and the approach works far better in a dish than as a proven therapy, so claims about it should be read cautiously.
In the lab, scientists have forced ordinary connective-tissue cells (fibroblasts) to make a small set of nerve-cell master transcription factors, converting them directly into neuron-like cells — without ever turning them into stem cells in between.
Direct conversion: fibroblasts pushed straight toward neuron-like cells, skipping pluripotency.
Transdifferentiation skips the pluripotent stage that iPSC reprogramming passes through — so it is not the same as making iPSCs, and converted cells can remain incompletely or unstably transformed.